Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | APVO | Common Stock | Purchase | $650 | +714 | +89.03% | $0.91* | 1.52K | Jun 14, 2019 | Direct | F2 |
transaction | APVO | Common Stock | Options Exercise | +298 | +19.66% | 1.81K | Jun 1, 2022 | Direct | F3 | ||
holding | APVO | Common Stock | 802 | Aug 3, 2016 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | APVO | Restricted Stock Unit | Options Exercise | $0 | -298 | -33.37% | $0.00 | 595 | Jun 1, 2022 | Common Stock | 298 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective August 1, 2016, and adjusted to reflect a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020. |
F2 | Reflects a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020. |
F3 | Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
F4 | On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022. |